We found that PTHrP (1–34) injection did not change serum calcium and phosphate levels, which is consistent with previous studies [16,47,48], indicating that up to 160 μg/kg PTHrP (1–34) does not cause hypercalcemia. The gene discussed is PTHLH; the disease is hypercalcemia disease.